XML 30 R17.htm IDEA: XBRL DOCUMENT v2.4.1.9
C. STOCKHOLDERS EQUITY (Tables)
 6 Months Ended
Mar. 31, 2015
C. Stockholders Equity Tables  
Stock options, stock bonuses and compensation granted by the Company

 

Name of Plan   Total Shares Reserved Under Plans     Shares Reserved for Outstanding Options     Shares Issued as Stock Bonus     Remaining Options/Shares Under Plans  
                         
Incentive Stock Options Plans     1,960,000       1,708,331       N/A       5,969  
Non-Qualified Stock Option Plans     5,680,000       5,055,402       N/A       67,679  
Stock Bonus Plans     1,594,000       N/A       1,303,491       289,753  
Stock Compensation Plan     1,350,000       N/A       1,316,949       -  
Incentive Stock Bonus Plan     16,000,000       N/A       15,600,000       400,000  

 

  Stock options granted and forfeited during the six and three months ended March 31, 2015 and 2014 are as follows:

 

    Six Months Ended March 31,  
    2015     2014  
 Granted     2,000       743,040  
 Forfeited     109,416       -  
                 
    Three Months Ended March 31,  
      2015       2014  
Granted     1,000       743,040  
Forfeited     11,916       -  
Schedule of employees and non-employees stock compensation
    Six Months Ended March 31,  
    2015     2014  
 Employees   $ 3,951,854     $ 1,030,429  
 Non-employees   $ 300,129     $ 421,509  

 

    Three Months Ended March 31,  
    2015     2014  
 Employees   $ 892,063     $ 520,151  
 Non-employees   $ 110,985     $ 206,789  
Derivative Liabilities, Warrants and Other Options

Warrant   Issue Date   Shares Issuable upon Exercise of Warrant     Exercise Price   Expiration Date   Reference  
                         
Series H   1/26/12     1,200,000     $ 5.00   8/1/15     1  
Series Q   6/21/12     1,200,000     $ 5.00   12/22/15     1  
Series R   12/6/12     2,625,000     $ 4.00   12/6/16     1  
Series S   10/11/13 -10/24/14     25,928,010     $ 1.25   10/11/18     1  
Series U   4/17/14     445,514     $ 1.75   10/17/17     1  
Series L (repriced)   4/18/07     70,000     $ 2.50   4/2/15     2  
Series N   8/18/08     2,844,627     $ 0.53   8/18/15     2  
Series P   2/10/12     590,001     $ 4.50   3/6/17     2  
Consultants   10/14/05– 3/30/15     188,000     $ 0.85-$20.00   10/14/15 -3/29/2018     3  
Tabular disclosure of derivative liabilities at fair value

The table below presents the derivative instruments outstanding at the balance sheet dates and their respective balances:

 

    March 31, 2015     September 30, 2014  
Series A through E warrants   $ -     $ 6,105  
Series H warrants     12,000       12,000  
Series Q warrants     12,000       12,000  
Series R warrants     131,250       157,500  
Series S warrants     8,296,963       5,197,352  
Series U warrants     133,596       120,289  
Total derivative liabilities   $ 8,585,809     $ 5,505,246  

  
Schedule Of Gains and (Losses) on Derivative Liabilities

The table below presents the gains and (losses) on the derivative instruments for the six months ended March 31:

 

    2015     2014  
Series A through E warrants   $ 6,105     $ (24,423 )
Series F and G warrants     -       (36,666 )
Series H warrants     -       (36,000 )
Series N warrants     -       (1,404,027 )
Series Q warrants     -       (72,000 )
Series R warrants     26,250       (183,750 )
Series S warrants     (2,638,874 )     (3,764,665 )
Series U warrants     (13,307 )     -  
Net loss on derivative instruments   $ (2,619,826 )   $ (5,521,531 )

 

The table below presents the losses on the derivative instruments for the three months ended March 31:

 

    2015     2014  
Series A through E warrants   $ -     $ (24,423 )
Series F and G warrants     -       (36,666 )
Series H warrants     -       (60,000 )
Series N warrants     -       (914,273 )
Series Q warrants     -       (96,000 )
Series R warrants     (105,000 )     (315,000 )
Series S warrants     (4,589,257 )     (5,685,986 )
Series U warrants     (88,539 )     -  
Net loss on derivative instruments   $ (4,782,796 )   $ (7,132,348 )